1. Home
  2. VERU

VERU

Veru Inc.

Logo Veru Inc.

Health Care

Biotechnology: Pharmaceutical Preparations

Nasdaq

as 04-19-2024 4:00pm EST

$
-
.
-
-
-
$
-
.
-
-
-
-
.
-
-
%

Veru Inc is a biopharmaceutical company with a drug development program for the treatment of metabolic diseases, oncology and acute respiratory distress syndrome (ARDS). The company is also in the late stage development of certain drugs for management of breast and prostate cancers. It also has a sexual health program which includes two products, ENTADFI, for the treatment of benign prostatic hyperplasia (BPH) and the FC2 Female Condom (Internal Condom). The company operates in single segment and generates revenue from USA which is the key revenue generating market, South Africa and other regions.

Founded: N/A Country:
United States
United States
Employees: 233 City: MIAMI
Market Cap: 191.8M IPO Year: 1990
Target Price: $2.75 AVG Volume (30 days): 2.5M
Analyst Decision: Buy Number of Analysts: 4
Dividend Yield: N/A Dividend Payout Frequency: N/A
EPS: -0.75 EPS Growth: N/A
52 Week Low/High: $0.36 - $1.92 Next Earning Date: 05-09-2024
Revenue: $15,929,890 Revenue Growth: -42.55%
Revenue Growth (this year): 14.75% Revenue Growth (next year): -45.45%

Share on Social Networks: